The Allstate Corporation logo ALL - The Allstate Corporation

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
1
BUY 18
HOLD 22
SELL 4
STRONG
SELL
0
| PRICE TARGET: $268.14 DETAILS
HIGH: $319.00
LOW: $226.00
MEDIAN: $266.50
CONSENSUS: $268.14
UPSIDE: 2.90%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Undervalued Moderate
Trading 30.3% below fair value
Current Price $260.58
Bear Case $322.76 23.9% upside ($322.76 - $260.58) / $260.58 = 23.9% ROTCE 20.0% → 4.00x TBV
Fair Value $373.78 43.4% upside ($373.78 - $260.58) / $260.58 = 43.4% ROTCE 25.0% → 4.00x TBV
Bull Case $485.91 86.5% upside ($485.91 - $260.58) / $260.58 = 86.5% ROTCE 30.0% → 4.00x TBV

Adjust Assumptions

49.5%
6.0%

Key Value Driver

ROTCE (49.5%) vs. cost of equity (6.0%)

Implied Market Multiple 3.23x

Plain-Language Summary

With ROTCE of 49.5% vs. 6.0% cost of equity, fair P/TBV is 4.00x on $80.69 tangible book, implying $373.78 per share. DDM cross-check: $358.91.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (45 analysts) $268.14
Analyst Range $226.00 – $319.00
Divergence from AlphaVal 39%

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Wall Street's average price target is $268.14 (from 45 analysts). Our estimate is 39% above the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly